Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Legend Biotech
Pharma
GSK-Hengrui, Takeda, Celltrion—Fierce Pharma Asia
GSK signed a 12-asset licensing deal with Hengrui. Generic erosion on Vyvanse pulled back Takeda. Celltrion plans to buy a large U.S. facility.
Angus Liu
Aug 1, 2025 9:00am
J&J, Legend debut first TV ad for multiple myeloma med Carvykti
Jul 30, 2025 2:56pm
FDA removes barrier to CAR-Ts; move likely to boost uptake
Jun 27, 2025 11:14am
Orca hires ex-Legend exec Gavel to target cell therapy market
Jun 5, 2025 11:58am
ASCO: Amgen's Imdelltra prolongs life in small cell lung cancer
Jun 2, 2025 8:00am
Takeda, Sun, Ono—Fierce Pharma Asia
Mar 14, 2025 8:45am
